| Acquirer | Target | Price |
|---|---|---|
| GlaxoSmithKline | Rights to Azymetric platform | $36 million |
| AbbVie | Stemcentrx, Inc. | $5.8 billion |
| Luye Medical Group Pte Ltd | Healthe Care Australia Pty Ltd | $688 million |
| Abbott | St. Jude Medical | $30.7 billion |
| Leonard Green & Partners, LP | ExamWorks Group | $2.2 billion |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
